Nuclera Nucleics
2013
FOUNDED
PRIVATE
STATUS
Accelerator/Inc
LATEST DEAL TYPE
4
INVESTORS
Description
Owner and operator of a DNA synthesis company intended to create a DNA synthesis platform capable of manufacturing genomes on-demand. The company's platform is based on engineered terminal deoxynucleotidyl transferases and its enzymes are proven to quantitatively incorporate a wide variety of reversibly terminating nucleotide triphosphates of all four nucleobases, enabling users to conduct the production of gene and genome libraries.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Social/Platform Software
Other Industries
Biotechnology
Primary Office
- 152 Cambridge Science Park
- Milton Road
- Cambridge CB4 0GN
- England, United Kingdom
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Nuclera Nucleics’s full profile, request a free trial.
Nuclera Nucleics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 22-Feb-2017 | 00000 | Completed | Generating Revenue | ||
| 5. Grant | 01-Jul-2015 | 00000 | 00000 | Completed | Generating Revenue | |
| 4. Grant | 01-Jul-2014 | 000.00 | 00000 | Completed | Generating Revenue | |
| 3. Grant | 01-May-2014 | 00000 | 00000 | Completed | Generating Revenue | |
| 2. Accelerator/Incubator | $837K | Completed | Generating Revenue | |||
| 1. Seed Round | 01-May-2014 | $837K | $837K | Completed | Generating Revenue |
Nuclera Nucleics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Bio-start | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| Nwes | Corporation | 000 0000 | 000000 0 | |||
| Innovate UK | Government | 000 0000 | 000000 0 | |||
| Accelerate Cambridge | Accelerator/Incubator | 000 0000 | 000000 0 |